Det er sandsynligt at eliminationen af alendronat via nyrerne vil være reduceret hos patienter med nyreinsufficiens, ligesom den er hos dyr, men der foreligger ingen klinisk dokumentation for dette.
Although no clinical information is available, it is likely that, as in animals, elimination of alendronate via the kidney will be reduced in patients with impaired renal function.